Diabetic retinopathy develops through complex microvascular damage driven by chronic hyperglycemia, yet traditional risk factors such as disease duration or glycemic control explain only part of ...

Company advances Phase 3 AXPAXLI programs, with SOL-1 Week 52 data presentation set for February 2026 and SOL-R topline expected in Q1 2027.

Diabetic retinopathy develops through complex microvascular damage driven by chronic hyperglycemia, yet traditional risk factors such as disease duration or glycemic control explain only part of ...

At Envision Summit 2026, the “Fast and Fundus” retina panel delivered rapid-fire case discussions grounded in practical ...

Tear fluid is emerging as an attractive source of diagnostic information because it can be collected easily and noninvasively ...

For people living with diabetes, the biggest threat to their eyesight often arrives with no symptoms. Diabetic retinopathy, ...

Although the prevalence of diabetes-related eye diseases almost doubled since 2014, the rates of most severe forms of the disease have actually decreased, according to a new study led by researchers ...

More recently established treatments for RVO have taken a giant leap forward from laser photocoagulation since intravitreally ...

Microaneurysms are tiny areas of swelling in the blood vessels of your eye. They can be a clue to worsening diabetic retinopathy and may indicate that you need treatment to help prevent vision loss.